| Product ID |
CAS Number |
Product Name |
Quantity |
| A1-0288 |
857388-33-1 |
1-N-Phenyl-2-methylpiperidin-4-one |
|
| A1-0614 |
|
3-(N-Cbz-amino)azetidine HCl |
|
| A1-0644 |
53871-06-0 |
1-Benzhydrylazetidine-3-carboxylic acid methyl ester |
|
| A1-0649 |
122536-76-9 |
(S)-(+)-3-(Boc-Amino)pyrrolidine |
|
| A1-30010 |
526-18-1 |
2-Hydroxy-N-(4-hydroxyphenyl)-benzamide |
|
| A1-6218 |
1142-20-7 |
Benzyloxycarbonyl-L-alanine |
|
| JR6-L2093 |
712321-62-5 |
Benzenepropanoic acid, ß-amino-4-methoxy-ß-methyl-, (ßR)- |
|
| JR6-L2519 |
918625-32-8 |
L-Phenylalanine, 4-fluoro-ß-(4-fluorophenyl)-, hydrochloride (1:1) |
|
| JR6-L2540 |
1118750-58-5 |
D-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-4-fluoro-ß-(4-fluorophenyl)- |
|
| JR6-L2756 |
|
(S)-1-(2,3-difluorophenyl)propan-2-ol |
|
| JR6-L3808 |
1082604-44-1 |
Cyclopentanecarboxylic acid, 2-(aminomethyl)-1-methyl-, (1R,2R)- |
|
| JR6-L4240 |
1019110-92-9 |
Phenol, 4,4'-[[1-(4-fluorophenyl)-1H-pyrazole-3,5-diyl]di-(1E)-2,1-ethenediyl]bis[2-methoxy- |
|
| JR6-L4947 |
749269-73-6 |
Cyclopropanecarbonitrile, 1-(4-bromo-3-fluorophenyl)- |
|
| JR6-L6630MIX |
1648825-53-9 |
PhenoFluorMix |
|
| JR6-L6804 |
74672-53-0 |
3H-Pyrazol-3-one, 2-(2-chloro-4-nitrophenyl)-2,4-dihydro-5-(trifluoromethyl)- |
|
| JR6-L7001 |
1228185-09-8 |
2-CHLORO-1,3-BIS(2,6-DIISOPROPYLPHENYL)-1H-IMIDAZOL-3-IUM CHLORIDE |
|
| JR6-L7148 |
76757-90-9 |
N-tBoc-D-tyrosine methyl ester |
|
| JR6-L7184 |
7442-07-1 |
6-AMINO-2-BENZOTHIAZOLETHIOL |
|
| JR6-L7811 |
1029431-50-2 |
Oxirane, 2-(4-iodophenyl)-, (2R)- |
|
| JR6-L7815 |
208343-02-6 |
Oxirane, 2-(1-naphthalenyl)-, (2R)- |
|
| JR8-N0084 |
551-15-5 |
Liquiritin |
|
| JR8-N0267 |
|
20(R)Ginsenoside Rh1 |
|
| JR8-N0654 |
510-30-5 |
Echinocystic acid |
|
| JR8-N0811 |
|
(+)-lyoniresinol-3a-O-(6''-3,5-dimethoxy-4-hydroxybenzoyl)-ß-D-glucopyranoside |
|
| JR8-N0823 |
|
Angeliticin A |
|
| JR8-N0826 |
36150-06-8 |
Saxalin |
|
| JR8-N0973 |
470-82-6 |
Cineole |
|
| JR8-N1034 |
57396-78-8 |
Oroxin A |
|
| JR8-N1203 |
5373-11-5 |
Luteolin-7-O-glucoside |
|
|
|
|
|
|
|
|
|
|
|
|
|